Nanoform Finland Oyj

Helsinki Stock Exchange NANOFH.HE

Nanoform Finland Oyj Revenue for the year ending December 31, 2023: USD 2.83 M

Nanoform Finland Oyj Revenue is USD 2.83 M for the year ending December 31, 2023, a -24.08% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Nanoform Finland Oyj Revenue for the year ending December 31, 2022 was USD 3.73 M, a 67.70% change year over year.
Nanoform Finland Oyj Revenue for the year ending December 31, 2021 was USD 2.22 M, a 165.22% change year over year.
Nanoform Finland Oyj Revenue for the year ending December 31, 2020 was USD 838.91 K, a 1,422.70% change year over year.
Nanoform Finland Oyj Revenue for the year ending December 31, 2019 was USD 55.09 K, a -79.52% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Helsinki Stock Exchange: NANOFH.HE

Nanoform Finland Oyj

CEO	Prof. Edward Olof Haeggstrom
IPO Date	June 4, 2020
Location	Finland
Headquarters	Cultivator II
Employees	174
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials Engineering Services

Description

Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients. The company was founded in 2008 and is headquartered in Helsinki, Finland.

Key trends

Past 5 years